ACT Lung Health Intervention for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help Chinese and Korean American smokers quit smoking, aiming to reduce their risk of lung cancer. Participants will either receive the new counseling program (ACT Lung Health Intervention) or standard care while researchers monitor them through surveys and tests over six months. This trial suits current smokers with a long history of smoking who have not recently undergone a specific lung screening test. Participants should also live in the U.S. and have access to a device for video calls.
As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could benefit the community.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this counseling and educational program is safe for improving lung health?
Research has shown that programs designed to help people stop smoking, such as the ACT Lung Health Intervention, are generally manageable for participants. In studies of similar programs, participants have not reported any major side effects. These programs emphasize counseling and education to aid in quitting smoking, without the need for new medications or medical procedures.
Regular check-ins and support sessions are often included, which participants in similar studies have found helpful and safe. Safety concerns remain low because the program employs behavior change techniques instead of new drugs, reducing the risks typically associated with medication trials.
Overall, evidence suggests these programs are safe, with participants primarily experiencing positive outcomes in quitting smoking.12345Why are researchers excited about this trial?
Researchers are excited about the ACT Lung Health Intervention because it takes a fresh approach to helping people quit smoking. Unlike traditional methods like nicotine replacement therapies and prescription medications, this intervention incorporates Acceptance and Commitment Therapy (ACT) principles. ACT focuses on helping individuals accept their cravings and commit to quitting without fighting their urges head-on. This psychological approach, combined with regular support through weekly Zoom sessions and personalized strategies, offers a unique and potentially more effective way to address the emotional and mental challenges of quitting smoking.
What evidence suggests that the ACT Lung Health Intervention is effective for smoking cessation?
Studies have shown that Acceptance and Commitment Therapy (ACT) can help people quit smoking. Research indicates that a smartphone app based on ACT proved more effective in helping users quit than a typical smoking cessation app. Another study found that people using the ACT method were more likely to attempt quitting compared to those using other methods. Typically, without structured help, only about 3%-5% of people successfully quit smoking. In this trial, participants in Group A will receive the ACT Lung Health Intervention, which could be a promising way to support quitting smoking and improve lung health. Meanwhile, participants in Group B will receive standard care.678910
Who Is on the Research Team?
Mary Cooley, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
The ACT Lung Health Intervention trial is for Chinese and Korean American smokers aged 50-80 with a significant smoking history, who currently smoke and have health insurance, a primary healthcare provider, and can video-call. Excluded are those under 50 or over 80, unable to consent, pregnant women, prisoners, recent serious mental illness hospitalization or previous lung cancer.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline visit and initial questionnaires
Intervention
Participants receive counseling and educational program for smoking cessation
Follow-up
Participants are monitored for smoking abstinence and lung cancer screening completion
What Are the Treatments Tested in This Trial?
Interventions
- ACT Lung Health Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
University of Massachusetts, Boston
Collaborator